Standard
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction. / Baker, Jason V; Neuhaus, Jacqueline; Duprez, Daniel; Freiberg, Matthew; Bernardino, Jose I; Badley, Andrew D; Nixon, Daniel E; Lundgren, Jens D; Tracy, Russell P; Neaton, James D; INSIGHT SMART Study Group.
In:
Journal of acquired immune deficiency syndromes (1999), Vol. 60, No. 2, 01.06.2012, p. 128-34.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Baker, JV, Neuhaus, J, Duprez, D, Freiberg, M, Bernardino, JI, Badley, AD, Nixon, DE
, Lundgren, JD, Tracy, RP, Neaton, JD & INSIGHT SMART Study Group 2012, '
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction',
Journal of acquired immune deficiency syndromes (1999), vol. 60, no. 2, pp. 128-34.
https://doi.org/10.1097/QAI.0b013e318252f99fAPA
Baker, J. V., Neuhaus, J., Duprez, D., Freiberg, M., Bernardino, J. I., Badley, A. D., Nixon, D. E.
, Lundgren, J. D., Tracy, R. P., Neaton, J. D., & INSIGHT SMART Study Group (2012).
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
Journal of acquired immune deficiency syndromes (1999),
60(2), 128-34.
https://doi.org/10.1097/QAI.0b013e318252f99fVancouver
Baker JV, Neuhaus J, Duprez D, Freiberg M, Bernardino JI, Badley AD et al.
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.
Journal of acquired immune deficiency syndromes (1999). 2012 Jun 1;60(2):128-34.
https://doi.org/10.1097/QAI.0b013e318252f99fAuthor
Baker, Jason V ; Neuhaus, Jacqueline ; Duprez, Daniel ; Freiberg, Matthew ; Bernardino, Jose I ; Badley, Andrew D ; Nixon, Daniel E ; Lundgren, Jens D ; Tracy, Russell P ; Neaton, James D ; INSIGHT SMART Study Group. / HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction. In: Journal of acquired immune deficiency syndromes (1999). 2012 ; Vol. 60, No. 2. pp. 128-34.
Bibtex
@article{3519c254dfc34c33a5ed831b65a28d40,
title = "HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction",
abstract = "HIV infection is associated with premature development of cardiovascular disease. Understanding the effects of HIV replication on endothelial dysfunction and platelet activation may identify treatment targets to reduce cardiovascular disease risk.",
keywords = "Adult, Anti-HIV Agents, Antigens, CD40, Antiretroviral Therapy, Highly Active, Arginine, Biological Markers, Female, HIV Infections, Humans, Inflammation, Male, Middle Aged, P-Selectin, Plasma, Randomized Controlled Trials as Topic, Virus Replication",
author = "Baker, {Jason V} and Jacqueline Neuhaus and Daniel Duprez and Matthew Freiberg and Bernardino, {Jose I} and Badley, {Andrew D} and Nixon, {Daniel E} and Lundgren, {Jens D} and Tracy, {Russell P} and Neaton, {James D} and {INSIGHT SMART Study Group}",
year = "2012",
month = jun,
day = "1",
doi = "10.1097/QAI.0b013e318252f99f",
language = "English",
volume = "60",
pages = "128--34",
journal = "J A I D S",
issn = "1525-4135",
publisher = "Lippincott Williams & Wilkins",
number = "2",
}
RIS
TY - JOUR
T1 - HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction
AU - Baker, Jason V
AU - Neuhaus, Jacqueline
AU - Duprez, Daniel
AU - Freiberg, Matthew
AU - Bernardino, Jose I
AU - Badley, Andrew D
AU - Nixon, Daniel E
AU - Lundgren, Jens D
AU - Tracy, Russell P
AU - Neaton, James D
AU - INSIGHT SMART Study Group
PY - 2012/6/1
Y1 - 2012/6/1
N2 - HIV infection is associated with premature development of cardiovascular disease. Understanding the effects of HIV replication on endothelial dysfunction and platelet activation may identify treatment targets to reduce cardiovascular disease risk.
AB - HIV infection is associated with premature development of cardiovascular disease. Understanding the effects of HIV replication on endothelial dysfunction and platelet activation may identify treatment targets to reduce cardiovascular disease risk.
KW - Adult
KW - Anti-HIV Agents
KW - Antigens, CD40
KW - Antiretroviral Therapy, Highly Active
KW - Arginine
KW - Biological Markers
KW - Female
KW - HIV Infections
KW - Humans
KW - Inflammation
KW - Male
KW - Middle Aged
KW - P-Selectin
KW - Plasma
KW - Randomized Controlled Trials as Topic
KW - Virus Replication
U2 - 10.1097/QAI.0b013e318252f99f
DO - 10.1097/QAI.0b013e318252f99f
M3 - Journal article
C2 - 22421746
VL - 60
SP - 128
EP - 134
JO - J A I D S
JF - J A I D S
SN - 1525-4135
IS - 2
ER -
